| | | | | |
YDES YD Bio Limited Ordinary Shares | €1,9236 | +4,01% | €243,46M | €39,61K | |
XCBE X3 Acquisition Corp. Ltd. Class A Ordinary Shares | €8,6629 | -0,20% | €243,15M | €6,106 | |
ALXO ALX Oncology Holdings Inc. Common Stock | €1,7797 | +2,00% | €243,00M | €539,87K | |
DUOT Duos Technologies Group, Inc. Common Stock | €7,2584 | -1,65% | €242,80M | €502,16K | |
AXIN Axiom Intelligence Acquisition Corp 1 Class A Ordinary Shares | €8,9988 | -0,15% | €242,63M | €33,55K | |
PMM Putnam Managed Municipal Income | €5,7317 | +0,31% | €242,14M | €42,02K | |
ADAG Adagene Inc. American Depositary Shares | €3,1843 | +1,11% | €241,51M | €34,54K | |
GLOO Gloo Holdings, Inc. Class A Common Stock | €2,9400 | -0,30% | €241,41M | €369,08K | |
NXDT NexPoint Diversified Real Estate Trust | €4,9727 | -1,04% | €241,41M | €141,84K | |
POWW Outdoor Holding Company Common Stock | €2,0676 | -0,84% | €241,19M | €502,21K | |
NAGE Niagen Bioscience, Inc. Common Stock | €3,0272 | +5,47% | €241,10M | €765,61K | |
SENS Senseonics Holdings, Inc. Common Stock | €4,4841 | +2,19% | €240,91M | €349,07K | |
OSG Octave Specialty Group, Inc. | €5,0512 | -5,39% | €240,72M | €345,04K | |
| €3,1668 | +0,55% | €239,85M | €941,61K | |
NHIV NewHold Investment Corp IV Class A Ordinary Shares | €8,8069 | +0,15% | €239,68M | €186,69 | |
